Novel Vaginal Drug Delivery Systems

Dear Colleagues,

The intravaginal administration of drugs constitutes a longstanding and valuable practice in the promotion of women’s health. Major advances have been achieved in the field over the last two decades, largely propelled by the development of vaginal microbicides for preventing sexual HIV transmission. The ongoing regulatory approval of the dapivirine ring in various countries is just one good example of the accomplishments made in this area. Other clinical applications have also benefited from such developments (e.g., the treatment of sexually transmitted infections, contraception, pregnancy support, etc.) and their clinical translation is already in progress. Proper design and testing of drug delivery systems and dosage forms play a key role in the success of products intended for vaginal use, but, despite all the excitement in the field, substantial work and innovative solutions are still needed. As guest editors, we would like to encourage colleagues to submit their research work in the format of full papers or communications, as well as pertinent reviews, in all subjects pertaining to the development and characterization of drug delivery systems intended for human or veterinary vaginal use, and with application in diagnostics, imaging, therapy, prophylaxis or regenerative medicine.

Dr. José das Neves
Dr. Fernando Notario-Pérez
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.